483
N-Molecular Inc. d.b.a. SOFIEFDA 483 - N-Molecular Inc. d.b.a. SOFIE - February 28, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
M-Molecular Inc. d.b.a. SOFIE in Haverhill, MA, a sterile PET drug manufacturer, received a Form 483 with six observations. The inspection revealed significant deficiencies in equipment suitability and maintenance, production and process controls for aseptic manufacturing, facility contamination prevention, and adherence to quality assurance procedures. These issues indicate a lack of robust controls to ensure product quality and sterility.
Open in Dashboard
ID · 63e55155-fdc5-46fd-bc44-97f4303d19ea